FDA Investigator: Lily Y. Koo
- Lily Y. Koo first started conducting FDA inspections in 2018, with the last inspection in 2021. Over that time, Lily Y. Koo has conducted 4 inspections at 4 companies across 4 sites.
Get Lily Koo's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Duke University School of Medicine, Carolinas Cord Blood Bank, Durham | 2019
Out-of-stock
Lily Y. Koo
Biologic Form 483
FDA 483 GlaxoSmithKline Biologicals, St Amand Les Eaux | 2018
Out-of-stock
Lily Y. Koo
Biologic Form 483
FDA 483 Baxalta US Inc., Social Circle | 2018
Out-of-stock
Lily Y. Koo
Biologic Form 483
Co-Investigators (17)
- Jacqueline M. Diaz Albert, FDA Investigator
- Graeme E. Price, FDA Investigator
- Zhaohui Ye, FDA Investigator
- David E. Bailey, FDA Investigator
- Jacqueline M. Diaz Albertini, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Diaz Albertini, Jacqueline M, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Ekaterina Allen, FDA Investigator
- Sukhanya Jayachandra, FDA Investigator
- Thomas P. Finn, FDA Investigator
- Randa Melhem, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Yonggang Wang, FDA Investigator
- Deborah M. Trout, FDA Investigator
- Michael C. Kennedy, FDA Investigator
- Silvia Wanis, FDA Investigator